Bloodworkthe quarterly ground truth
63 markers · drawn 2026-06-05 (Quest, Culver City, 14h fasted) · vs 3 prior panels
P-2025-11P-2026-02P-2026-05P-2026-06Sample
Markers Tracked
63
8 panels, quarterly cadenceOptimal
61
97% of panelIn Progress
2
omega-3 index closingWatch / Flag
0
nothing red on this drawBiological Age*
17.8yr
*PhenoAge estimate, chrono 21Next Draw
Sep 04
adds insulin clamp + DEXAFull Panel — All Sections
P-2026-06TREND = 4 DRAWS · NOV 25 → JUN 26
| Marker | Current | Prev | Δ | Unit | Lab Ref | Optimal | Trend (4 draws) | Status | Notes |
|---|---|---|---|---|---|---|---|---|---|
| Lipids & Cardiovascular · 10 markers | |||||||||
| ApoB | 72 | 78 | −6 | mg/dL | < 90 | < 80 | optimal | Primary CV risk marker. Down 24 pts since Nov. | |
| LDL-C | 89 | 96 | −7 | mg/dL | < 100 | < 100 | good | ||
| HDL-C | 61 | 58 | +3 | mg/dL | > 40 | > 55 | optimal | ||
| Triglycerides | 62 | 68 | −6 | mg/dL | < 150 | < 80 | optimal | ||
| ApoA1 | 153 | 149 | +4 | mg/dL | > 120 | > 140 | optimal | ||
| Lp(a) | 30 | 29 | +1 | nmol/L | < 75 | < 75 | optimal | Genetically set. Re-test annually only. | |
| Total Cholesterol | 162 | 168 | -6 | mg/dL | < 200 | 150-200 | optimal | ||
| Non-HDL-C | 101 | 110 | −9 | mg/dL | < 130 | < 110 | optimal | ||
| TG : HDL ratio | 1.02 | 1.17 | −0.15 | — | < 2.0 | < 1.5 | optimal | ||
| Oxidized LDL | 42 | 45 | −3 | U/L | < 60 | < 45 | optimal | ||
| Metabolic & Glycemic · 7 markers | |||||||||
| Fasting Glucose | 88 | 90 | −2 | mg/dL | 65-99 | 70-90 | optimal | ||
| Fasting Insulin | 4.1 | 4.6 | −0.5 | uIU/mL | 2.6-24.9 | < 5.0 | optimal | ||
| HOMA-IR | 0.89 | 1.02 | −0.13 | — | < 2.0 | < 1.0 | optimal | Insulin sensitivity now elite-range. | |
| HbA1c | 5.0 | 5.1 | −0.1 | % | 4.8-5.6 | < 5.4 | optimal | ||
| Uric Acid | 5.4 | 5.6 | −0.2 | mg/dL | 3.8-8.4 | < 6.0 | optimal | Watch with honey intake; trending right way. | |
| Adiponectin | 9.4 | 8.9 | +0.5 | ug/mL | > 5 | > 9 | optimal | ||
| Leptin | 3.4 | 3.6 | -0.2 | ng/mL | 0.5-13.8 | 2-5 | optimal | ||
| Inflammation & Oxidation · 5 markers | |||||||||
| hs-CRP | 0.5 | 0.6 | −0.1 | mg/L | < 3.0 | < 1.0 | optimal | Seed-oil elimination doing its job. | |
| Homocysteine | 8.6 | 9.1 | −0.5 | umol/L | < 15 | < 9.0 | optimal | ||
| Ferritin | 112 | 118 | -6 | ng/mL | 30-400 | 60-150 | optimal | ||
| Fibrinogen | 274 | 281 | −7 | mg/dL | 200-400 | < 300 | optimal | ||
| GGT | 15 | 16 | −1 | U/L | 3-70 | < 20 | optimal | ||
| Hormones · 9 markers | |||||||||
| Testosterone, Total | 742 | 715 | +27 | ng/dL | 264-916 | 600-900 | optimal | +130 since Nov on sleep + vitamin D. | |
| Testosterone, Free | 18.4 | 17.6 | +0.8 | pg/mL | 9.3-26.5 | > 15 | optimal | ||
| SHBG | 33 | 32 | +1 | nmol/L | 16.5-55.9 | 20-45 | optimal | ||
| Estradiol (sensitive) | 26 | 26 | 0 | pg/mL | 8-35 | 20-30 | optimal | ||
| Cortisol (8am) | 14.6 | 15.2 | -0.6 | ug/dL | 6.2-19.4 | 10-16 | optimal | Was upper-range in Nov during finals. | |
| DHEA-S | 441 | 428 | +13 | ug/dL | 164-530 | > 350 | optimal | ||
| IGF-1 | 268 | 262 | +6 | ng/mL | 115-355 | 200-280 | optimal | ||
| LH | 6.0 | 5.8 | +0.2 | mIU/mL | 1.7-8.6 | 4-8 | optimal | ||
| Prolactin | 8.4 | 8.6 | -0.2 | ng/mL | 4.0-15.2 | 5-12 | optimal | ||
| Thyroid · 4 markers | |||||||||
| TSH | 1.8 | 1.9 | -0.1 | uIU/mL | 0.45-4.5 | 1.0-2.5 | optimal | ||
| Free T3 | 3.5 | 3.4 | +0.1 | pg/mL | 2.0-4.4 | 3.2-4.2 | optimal | ||
| Free T4 | 1.3 | 1.3 | 0.0 | ng/dL | 0.82-1.77 | 1.1-1.6 | optimal | ||
| Reverse T3 | 14.0 | 14.4 | −0.4 | ng/dL | 9.2-24.1 | < 15 | optimal | ||
| Vitamins, Minerals & Fatty Acids · 10 markers | |||||||||
| Vitamin D, 25-OH | 48 | 45 | +3 | ng/mL | 30-100 | 40-60 | optimal | 5000 IU D3 + K2 since Dec. | |
| Omega-3 Index | 7.2 | 6.8 | +0.4 | % | > 4.0 | > 8.0 | good | Only marker still short of target. | |
| Vitamin B12 | 648 | 610 | +38 | pg/mL | 232-1245 | > 500 | optimal | ||
| Folate, RBC | 604 | 588 | +16 | ng/mL | > 280 | > 500 | optimal | ||
| Magnesium, RBC | 5.8 | 5.6 | +0.2 | mg/dL | 4.2-6.8 | 5.5-6.5 | optimal | Glycinate 400mg nightly closed the gap. | |
| Zinc, Plasma | 102 | 99 | +3 | ug/dL | 60-130 | 90-120 | optimal | ||
| Copper, Serum | 96 | 95 | +1 | ug/dL | 70-175 | 85-110 | optimal | ||
| Selenium | 144 | 141 | +3 | ug/L | 110-165 | 120-150 | optimal | ||
| Iron, Serum | 106 | 108 | -2 | ug/dL | 38-169 | 80-130 | optimal | ||
| Transferrin Saturation | 32 | 33 | -1 | % | 15-55 | 25-40 | optimal | ||
| Liver, Kidney & Electrolytes · 9 markers | |||||||||
| ALT | 19 | 21 | −2 | U/L | 9-46 | < 25 | optimal | ||
| AST | 27 | 26 | +1 | U/L | 10-40 | < 30 | optimal | Mild elevation expected with lifting volume. | |
| Creatinine | 1.21 | 1.22 | -0.01 | mg/dL | 0.76-1.27 | 0.9-1.25 | optimal | Elevated baseline from creatine + muscle mass. Cystatin C is the truth. | |
| Cystatin C | 0.80 | 0.81 | −0.01 | mg/L | 0.52-1.16 | < 0.9 | optimal | ||
| eGFR (cystatin) | 116 | 115 | +1 | mL/min | > 90 | > 105 | optimal | ||
| Albumin | 4.9 | 4.8 | +0.1 | g/dL | 3.8-4.9 | 4.5-5.0 | optimal | ||
| Sodium | 141 | 140 | +1 | mmol/L | 134-144 | 138-142 | optimal | ||
| Potassium | 4.5 | 4.4 | +0.1 | mmol/L | 3.5-5.2 | 4.2-4.8 | optimal | ||
| BUN | 22 | 22 | 0 | mg/dL | 6-24 | 12-22 | optimal | Upper-range, consistent with 1.9 g/kg protein. | |
| Complete Blood Count · 9 markers | |||||||||
| WBC | 5.4 | 5.2 | +0.2 | K/uL | 3.4-10.8 | 4.5-6.5 | optimal | ||
| RBC | 5.36 | 5.34 | +0.02 | M/uL | 4.14-5.80 | 5.0-5.6 | optimal | ||
| Hemoglobin | 15.9 | 15.8 | +0.1 | g/dL | 13.0-17.7 | 15-17 | optimal | ||
| Hematocrit | 46.9 | 46.6 | +0.3 | % | 37.5-51.0 | 44-50 | optimal | ||
| Platelets | 235 | 231 | +4 | K/uL | 150-450 | 200-300 | optimal | ||
| MCV | 90 | 89 | +1 | fL | 79-97 | 85-95 | optimal | ||
| RDW | 12.4 | 12.5 | −0.1 | % | 11.6-15.4 | < 13 | optimal | Low RDW correlates with biological youth. | |
| Neutrophils | 52 | 51 | +1 | % | 40-74 | 45-60 | optimal | ||
| Lymphocytes | 36 | 37 | -1 | % | 14-46 | 30-40 | optimal | ||
sample data · personal targets, not medical advice · panels parsed from lab pdfs into supabase via the n8n pipeline